:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Cameron James Parkin, Rajeev Jyoti, Peter Chin
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	BJUI Compass
Online-Zugang:	https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.392
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
von: Arjun Pon Avudaiappan, et al.
Veröffentlicht: (2024)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
von: Joshua Yi Min Tung, et al.
Veröffentlicht: (2026)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
von: Herbert Lepor, et al.
Veröffentlicht: (2025)

Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
von: Mario Dominguez Esteban, et al.
Veröffentlicht: (2025)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
von: Stijn M. van den Bosch, et al.
Veröffentlicht: (2026)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
von: Maxwell Louis Sandberg, et al.
Veröffentlicht: (2026)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
von: Esther H. J. Hamoen, et al.
Veröffentlicht: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
von: Samantha Shekar, et al.
Veröffentlicht: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
von: Eric V. Li, et al.
Veröffentlicht: (2024)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
von: Abel Tesfai, et al.
Veröffentlicht: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
von: Austin Drysch, et al.
Veröffentlicht: (2025)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
von: Ryan Sutherland, et al.
Veröffentlicht: (2024)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
von: Muhammad Imran, et al.
Veröffentlicht: (2026)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
von: Thomas Philip Cahill, et al.
Veröffentlicht: (2024)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
von: Abel Tesfai, et al.
Veröffentlicht: (2024)

Emerging tools for the early detection of prostate cancer
von: Muhammad Haider, et al.
Veröffentlicht: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
von: Jeremy Cheng, et al.
Veröffentlicht: (2025)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
von: Eric Margolis, et al.
Veröffentlicht: (2025)

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
von: Laurence Klotz, et al.
Veröffentlicht: (2024)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
von: See‐Tong Pang, et al.
Veröffentlicht: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
von: Ruth Pidsley, et al.
Veröffentlicht: (2024)

The carbon footprint of transperineal prostate biopsy
von: Daniel A. Carson, et al.
Veröffentlicht: (2025)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
von: Rodolfo Hurle, et al.
Veröffentlicht: (2025)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
von: Ansh Bhatia, et al.
Veröffentlicht: (2024)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
von: Sophia M. Abusamra, et al.
Veröffentlicht: (2025)

Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
von: Vincent J. Gnanapragasam, et al.
Veröffentlicht: (2025)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
von: Muhammad Haider, et al.
Veröffentlicht: (2025)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
von: Mohamad Baker Berjaoui, et al.
Veröffentlicht: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
von: Mohammed Shahait, et al.
Veröffentlicht: (2024)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
von: Alan Priester, et al.
Veröffentlicht: (2024)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
von: Jennifer Dunsmore, et al.
Veröffentlicht: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
von: Ailene E. Corona, et al.
Veröffentlicht: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
von: André B. Silva, et al.
Veröffentlicht: (2026)

Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
von: Lisa Browning, et al.
Veröffentlicht: (2025)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
von: Mathew Thakur, et al.
Veröffentlicht: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
von: Nikhil Mayor, et al.
Veröffentlicht: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
von: Nadia Rokan, et al.
Veröffentlicht: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
von: Emilien Seizilles de Mazancourt, et al.
Veröffentlicht: (2025)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
von: Geneva Pantoja, et al.
Veröffentlicht: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
von: Sofia Mesquita, et al.
Veröffentlicht: (2025)